Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment
Since the outbreak of corona virus disease 2019 (COVID-19) in Wuhan (China) in December 2019, the epidemic has rapidly spread to many countries around the world, posing a huge threat to global public health. In response to the pandemic, a number of clinical studies have been initiated to evaluate th...
Guardado en:
Autores principales: | Houwen Zou, Yuqi Yang, Huiqiang Dai, Yunchuang Xiong, Jing-Quan Wang, Lusheng Lin, Zhe-Sheng Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7a92b7d9574444fda508f1a1851626e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients
por: Chun-Rong Ju, et al.
Publicado: (2020) -
Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19
por: Panda PK, et al.
Publicado: (2021) -
NEUTROPHIL TO LYMPHOCYTE RATIO VS PLATELETS TO LYMPHOCYTE RATIO: BIOMARKERS TO PREDICT SEVERITY OF DISEASE AND THEIR COMPARISON IN PATIENTS OF COVID-19
por: Muhammad Adil, et al.
Publicado: (2020) -
Optic Nerve Head Optical Coherence Tomography Angiography Findings after Coronavirus Disease
por: Mojtaba Abrishami, et al.
Publicado: (2021) -
The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study
por: Colette Neethling, et al.
Publicado: (2021)